A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results

被引：2

作者：

Idowu, Modupe ^{[1
]}

Otieno, Lucas ^{[2
]}

Dumitriu, Bogdan ^{[3
]}

Lobo, Clarisse L. C. ^{[4
]}

Thein, Swee Lay ^{[5
]}

Andemariam, Biree ^{[6
]}

Nnodu, Obiageli E. ^{[7
]}

Inati, Adlette ^{[8
]}

Glaros, Alexander K. ^{[9
]}

Olalla Saad, Sara Teresinha ^{[10
,11
]}

Bartolucci, Pablo ^{[12
]}

Colombatti, Raffaella ^{[13
]}

Taher, Ali T. ^{[14
]}

Abboud, Miguel R. ^{[15
]}

Oluyadi, Abdulafeez ^{[16
]}

Iyer, Varsha ^{[16
]}

Yin, Ophelia ^{[17
,18
]}

Morris, Susan ^{[16
]}

Yates, Amber M. ^{[16
]}

Shao, Hui ^{[16
]}

Patil, Spurthi ^{[16
]}

Urbstonaitis, Rolandas ^{[16
]}

Zaidi, Ahmar U. ^{[16
]}

Smith, Wally R. ^{[19
]}

机构：

[1] UTHealth, McGovern Med Sch, Houston, TX USA

[2] Victoria Biomed Res Inst, Kisumu, Kenya

[3] Mid Atlantic Permanente Med Grp, Largo, MD USA

[4] HEMORIO, Div Res, Rio De Janeiro, Brazil

[5] NHLBI, Sickle Cell Branch, Bethesda, MD USA

[6] Univ Connecticut Hlth, New England Sickle Cell Inst, Farmington, CT USA

[7] Univ Abuja, Dept Haematol & Blood Transfus, Coll Hlth Sci, Ctr Excellence Sickle Cell Dis Res & Training, Abuja, Nigeria

[8] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos & NINI Hosp, Tripoli, Lebanon

[9] Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI USA

[10] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Hemoctr, Campinas, SP, Brazil

[11] Univ Campinas Unicamp, Campinas, Brazil

[12] Mondor Univ Hosp, Reference Ctr Sickle Cell Dis, Creteil, France

[13] Univ Padua, Pediat Hematol Oncol Unit, Padua, Italy

[14] Amer Univ Beirut, Med Ctr, Beirut, Lebanon

[15] Amer Univ, Dept Pediat & Adolescent Med, Beirut Med Ctr, Beirut, Lebanon

[16] Agios Pharmaceut Inc, Cambridge, MA USA

[17] ITeos Therapeut, Watertown, MA USA

[18] Agios Pharmaceut Inc, Time Res, Cambridge, MA USA

[19] Virginia Commonwealth Univ, Richmond, VA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[1] A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
Howard, Joanna
Kuo, Kevin H. M.
Oluyadi, Abdulafeez
Shao, Hui
Morris, Susan
Zaidi, Ahmar U.
Van Beers, Eduard J.
Thien, Swee Lay
BLOOD, 2021, 138
[2] Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global , double-blind, randomised, placebo-controlled trial
Idowu, Modupe
Otieno, Lucas
Dumitriu, Bogdan
Lobo, Clarisse L. C.
Thein, Swee Lay
Andemariam, Biree
Nnodu, Obiageli E.
Inati, Adlette
Glaros, Alexander K.
Bartolucci, Pablo
Colombatti, Raffaella
Taher, Ali
Abboud, Miguel R.
Darbari, Deepika
Ataga, Kenneth, I
Antmen, Ali Bulent
Kuo, Kevin H. M.
Medina, Samuel de Souza
Oluyadi, Abdulafeez
Iyer, Varsha
Morris, Susan
Yates, Amber M.
Shao, Hui
Patil, Spurthi
Urbstonaitis, Rolandas
Zaidi, Ahmar U.
Gheuens, Sarah
Smith, Wally R.
LANCET HAEMATOLOGY, 2025, 12 (01): : e35 - e44
[3] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
Goodman, A. D.
Rossman, H.
Bar-Or, A.
Miller, A.
Miller, D. H.
Schmierer, K.
Lublin, F.
Khan, O.
Bormann, N. M.
Yang, M.
Panzara, M. A.
Sandrock, A. W.
NEUROLOGY, 2009, 72 (09) : 806 - 812
[4] A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
Wun, Ted
Soulieres, Denis
Frelinger, Andrew L.
Krishnamurti, Lakshmanan
Novelli, Enrico M.
Kutlar, Abdullah
Ataga, Kenneth I.
Knupp, Charles L.
McMahon, Lillian E.
Strouse, John J.
Zhou, Chunmei
Heath, Lori E.
Nwachuku, Chuke E.
Jakubowski, Joseph A.
Riesmeyer, Jeffrey S.
Winters, Kenneth J.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
[5] A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
Ted Wun
Denis Soulieres
Andrew L Frelinger
Lakshmanan Krishnamurti
Enrico M Novelli
Abdullah Kutlar
Kenneth I Ataga
Charles L Knupp
Lillian E McMahon
John J Strouse
Chunmei Zhou
Lori E Heath
Chuke E Nwachuku
Joseph A Jakubowski
Jeffrey S Riesmeyer
Kenneth J Winters
Journal of Hematology & Oncology, 6
[6] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
Zou, Hejian
Wan, Weiguo
Xue, Yu
Sun, Lingyun
Zhang, Ning
Chen, Haiying
Shi, Xiaofei
Liu, Shengyun
Chen, Lin
Ma, Xinmei
Wei, Hua
Jiang, Zhenyu
Li, Xiaomei
Fan, Hongtao
Li, Hongbin
Li, Jingyang
Wu, Rui
Shi, Guixiu
Zhu, Jing
Kong, Xiaodan
Lu, Yuewu
Cui, Xiaojing
Zheng, Qianning
Bai, Xiaoyan
Dong, Guangchao
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
[7] Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial (vol 12, e35, 2025)
Idowu, M.
Otieno, L.
Dumitriu, B.
LANCET HAEMATOLOGY, 2025, 12 (03): : e175 - e175
[8] Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial (vol 25, pg E35, 2025)
Idowu, M.
Otieno, L.
Dumitriu, B.
LANCET HAEMATOLOGY, 2025, 12 (01): : e9 - e9
[9] ACTIVATE: A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN ADULTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
Al-Samkari, H.
Galacteros, F.
Glenthoj, A.
Rothman, J. A.
Andres, O.
Grace, R. F.
Morado Arias, M.
Layton, D. M.
Onodera, K.
Verhovsek, M.
Barcellini, W.
Judge, M. P.
Beynon, V.
Xu, E.
Hawkins, P.
Zagadailov, E.
Gheuens, S.
van Beers, E. J.
HAEMATOLOGICA, 2021, 106 (10) : 106 - 106
[10] ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused
Al-Samkari, H.
Galacteros, F.
Glenthoj, A.
Rothman, J. A.
Andres, O.
Grace, R. F.
Arias, Morado M.
Layton, D. M.
Onodera, K.
Verhovsek, M.
Barcellini, W.
Judge, M. P.
Beynon, V
Xu, E.
Hawkins, P.
Zagadailov, E.
Gheuens, S.
van Beers, E. J.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 40 - 40

← 1 2 3 4 5 →